SEARCH HEALTH CONDITIONS BY ALPHABETS
Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL
Medications for Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL
Other titles: Fredrickson Style V Hyperlipoproteinemia; Hyperlipoproteinemia, Fredrickson Type V
Around Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL: Hyperlipoproteinemia Type V is characterized by increased plasma levels of chylomicrons, VLDL, pre-β-lipoproteins, and triglycerides, and minor rise of cholesterol on a normal diet, with β-lipoproteins normal.
Drugs Used to Heal Hyperlipoproteinemia Type V, Elevated Chylomicrons VLDL
This list of medications have been in some way related to, or used in the treatment of this illness.
Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
fenofibrate | Rx | C | N | Insert inspection | 10 | ||
Generic name: fenofibrate systemic Brand titles: TriCor, Antara, Fenoglide, Lofibra, Lipofen, Triglide...show all Medicine class: fibric acid derivatives For consumers: dosage, interactions, For specialists: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
TriCor | Rx | C | N | Insert inspection | 10 | ||
Generic name: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Niaspan | Rx/OTC | C | N | Y | Insert inspection | 0.0 | |
Generic name: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
gemfibrozil | Rx | C | N | Insert inspection | 0.0 | ||
Generic name: gemfibrozil systemic Brand name: Lopid Medicine class: fibric acid derivatives For consumers: dosage, interactions, For specialists: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
niacin | Rx/OTC | C | N | Y | Insert inspection | 0.0 | |
Generic name: niacin systemic Brand titles: Niaspan, Niacin SR, Nicotinex, Slo-Niacin, Niacor, B3-500-Gr, B-3-50...series all Medicine category: nutritional supplements, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, For specialists: a Z Drug Truth, AHFS DI Monograph, Prescribing Information | |||||||
Antara | Rx | C | N | Insert inspection | 0.0 | ||
Generic name: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Fenoglide | Rx | C | N | Insert inspection | 0.0 | ||
Generic name: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Lofibra | Rx | C | N | Insert inspection | 0.0 | ||
Generic name: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Niacin SR | Rx/OTC | C | N | Y | Insert inspection | 0.0 | |
Generic name: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects | |||||||
Lipofen | Rx | C | N | Insert inspection | 0.0 | ||
Generic name: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Triglide | Rx | C | N | Insert inspection | 0.0 | ||
Generic name: fenofibrate systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
Nicotinex | Rx/OTC | C | N | Y | Insert inspection | 0.0 | |
Generic name: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects | |||||||
Slo-Niacin | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic name: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects | |||||||
Niacor | Rx/OTC | C | N | X | Insert inspection | 0.0 | |
Generic name: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
B3-500-Gr | Rx/OTC | C | N | Y | Insert inspection | 0.0 | |
Generic name: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects | |||||||
Lopid | Rx | C | N | Insert inspection | 0.0 | ||
Generic name: gemfibrozil systemic Medicine class: fibric acid derivatives For consumers: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
B-3-50 | Rx/OTC | C | N | Y | Insert inspection | 0.0 | |
Generic name: niacin systemic Medicine category: nutritional supplements, miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, negative effects | |||||||
Legend
Rx | Prescription Only |
---|---|
OTC | Over the Counter |
Rx/OTC | Prescription or Over The Counter |
Off Label | This medication might not be approved by the FDA for the treatment of the illness. |
Pregnancy Category | |
---|---|
A | sufficient and well-controlled studies have failed to demonstrate a risk to the embryo within the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in elderly women. |
C | Animal research studies have demonstrated an adverse effect on the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with use in elderly women clearly outweigh potential rewards. |
N | FDA has not classified this drug. |
Controlled Substances Act (CSA) Program | |
---|---|
N | Is not at the mercy of the Controlled Substances Act. |
1 | features a higher potential for abuse. Has no currently accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
Two | features a higher potential for abuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Psychotherapy can result in acute physical or emotional dependency. |
3 | includes a potential for abuse less than those in schedules 1 and two. Has a currently accepted medical use in treatment in the United States. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence. |
4 | features a very low potential for abuse in accordance with those in program 3. It`s a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence. |
5 | features a very low potential for abuse in accordance with those in program 4. Has a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to those in program 4. |
Infection | |
---|---|
X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always seek advice from your physician to ensure the information applies to a circumstances.